Securing America’s Pharmaceutical Innovation Edge
Bibliographic Data
| ID | 15808652 |
|---|---|
| Authors | Scott Gottlieb (0000-0002-9455-3671, American Enterprise Institute, corresponding author) |
| Year | 2025 |
| Volume | 6 |
| Issue | 8 |
| Pages | e254592-e254592 |
| Publication date | 2025-08-21 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | JAMA Health Forum (JOURNAL) |
| Journal identifiers | ISSN: 2689-0186 • E-ISSN: 2689-0186 |
| Publisher | American Medical Association (PUBLISHER • US) |
| DOI | 10.1001/jamahealthforum.2025.4592 |
| PMID | 40839250 |
| OpenAlex | W4413375912 |
| Language | EN |
| References cited | 3 |
This JAMA Forum discusses challenges to the US’s standing as a global leader in biomedical innovation from China, in the context of recent reductions in funding for biomedical research by the federal government
Business · China · Context (archaeology · Geography · Government (linguistics · Political science · Public relations · Biomedical Ethics and Regulation · Biotechnology and Related Fields · Law · Public Administration · Science, Research, and Medicine
| Highly cited | No |
|---|